The whole world of gambling is on your smartphone with the Mostbet app - join us!
Home  »  Hot Stocks   »  NexImmune Inc. (NEXI) Shares Rise Despite Market C...

NexImmune Inc. (NEXI) Shares Rise Despite Market Challenges

The stock of NexImmune Inc. (NASDAQ: NEXI) has increased by 30.00 when compared to last closing price of 0.20.Despite this, the company has seen a gain of 28.71% in its stock price over the last five trading days. PennyStocks reported 2023-02-17 that Use these tips for identifying penny stocks trends in 2023 The post How to Identify Trends With Penny Stocks in 2023  appeared first on Penny Stocks to Buy, Picks, News and Information |

Is It Worth Investing in NexImmune Inc. (NASDAQ: NEXI) Right Now?

, and the 36-month beta value for NEXI is at 2.24. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 1 as “hold,” and 0 as “sell.”

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


The average price suggested by analysts for NEXI is $5.00, The public float for NEXI is 18.72M, and currently, shorts hold a 0.44% of that float. The average trading volume for NEXI on September 18, 2023 was 149.93K shares.

NEXI’s Market Performance

NEXI’s stock has seen a 28.71% increase for the week, with a 13.04% rise in the past month and a -20.29% fall in the past quarter. The volatility ratio for the week is 14.01%, and the volatility levels for the past 30 days are at 11.06% for NexImmune Inc. The simple moving average for the past 20 days is 19.43% for NEXI’s stock, with a -24.09% simple moving average for the past 200 days.

Analysts’ Opinion of NEXI

Many brokerage firms have already submitted their reports for NEXI stocks, with Raymond James repeating the rating for NEXI by listing it as a “Outperform.” The predicted price for NEXI in the upcoming period, according to Raymond James is $30 based on the research report published on April 01, 2021 of the previous year 2021.

NEXI Trading at 2.35% from the 50-Day Moving Average

After a stumble in the market that brought NEXI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -68.79% of loss for the given period.

Volatility was left at 11.06%, however, over the last 30 days, the volatility rate increased by 14.01%, as shares surge +2.77% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -8.77% lower at present.

During the last 5 trading sessions, NEXI rose by +28.71%, which changed the moving average for the period of 200-days by -40.16% in comparison to the 20-day moving average, which settled at $0.2181. In addition, NexImmune Inc. saw 6.95% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at NEXI starting from BARER SOL J, who purchase 400,000 shares at the price of $0.41 back on Mar 30. After this action, BARER SOL J now owns 2,217,814 shares of NexImmune Inc., valued at $164,120 using the latest closing price.

BARER SOL J, the Director of NexImmune Inc., purchase 75,000 shares at $0.48 during a trade that took place back on Nov 17, which means that BARER SOL J is holding 1,817,814 shares at $35,918 based on the most recent closing price.

Stock Fundamentals for NEXI

The total capital return value is set at -107.75, while invested capital returns managed to touch -107.32. Equity return is now at value -161.70, with -125.90 for asset returns.

Based on NexImmune Inc. (NEXI), the company’s capital structure generated 3.17 points at debt to equity in total, while total debt to capital is 3.08. Total debt to assets is 2.38, with long-term debt to equity ratio resting at 1.32. Finally, the long-term debt to capital ratio is 1.28.

The liquidity ratio also appears to be rather interesting for investors as it stands at 3.62.


In conclusion, NexImmune Inc. (NEXI) has had a mixed performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.